Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
E-scape Bio Inc.
Headquarters: South San Francisco, CA, United States of America
Website: N/A
Year Founded: 2015
Status: Out of Business
BioCentury | Dec 9, 2021
Management Tracks
Wilson joins gene therapy play Rocket
Plus updates from Tessera, Oramed, Ikena and more
BioCentury | Mar 21, 2020
Management Tracks
Kutok joins Epizyme as CSO; plus ADC Therapeutics, Emulate, E-Scape, MiMedx and RubrYc
BioCentury | Dec 21, 2019
Company News
Management Tracks: Ionis promotes co-founder to CSO; Syros adds Celgene vet Alles to board; plus Encoded, Cygnal, Harvard Medical School, Immunitas and more
BioCentury | Sep 16, 2017
Finance
Local leverage
How Lilly Asia Ventures came to invest in U.S. companies
BioCentury | Sep 14, 2017
Strategy
Numerate’s Intelligence
How Numerate’s AI tackles translational questions with tiny data sets
BioCentury | Jul 21, 2017
Emerging Company Profile
Targeting APOE4
How E-Scape is changing APOE4’s structure to treat AD
BioCentury | Jul 15, 2017
Finance
E-scape's expansion
What neurology play E-Scape plans to do with its $63M series A round
Items per page:
1 - 10 of 11